Abstract

A procedure is described for quantifying norepinephrine [1(3,4-dihydroxyphenyl)-2-aminoethanol] and dopamine (4-(2-aminoethyl)-1,2-benzenediol] in cerebrospinal fluid by high-performance liquid chromatography (h.p.l.c.) with dual working-electrode electrochemical detection. An ion-pairing reversed-phase h.p.l.c. technique is used after clean-up and preconcentration of the fluid on alumina. The dual working-electrode electrochemical detector used provides amplification in the electrochemical response per unit concentration of material passing through the detector. This is achieved by locating two working electrodes on the opposite walls of a thin-layer cell, holding them close together and at potentials that will induce a sequence of oxidation/reductions. The greater the number of oxidation/reduction cycles, the greater the amplification of the electrochemical response. Peak height ratios are linear over the range expected and detection limits are 3 pg for norepinephrine and 5 pg for dopamine. The concentrations of norepinephrine and dopamine in human cerebrospinal fluid were found to be 141 pg ml −1 and 262 pg ml −1 with relative standard deviations of 6.8 and 5.8%, respectively.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.